U.S. Markets closed

Arcadia Biosciences, Inc. (RKDA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
2.9400+0.0600 (+2.08%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close2.8800
Open2.9000
Bid2.9200 x 800
Ask3.0300 x 800
Day's Range2.8800 - 2.9700
52 Week Range2.2600 - 6.4000
Volume209,299
Avg. Volume2,286,585
Market Cap62.728M
Beta (5Y Monthly)-0.73
PE Ratio (TTM)N/A
EPS (TTM)-0.4670
Earnings DateAug 11, 2021 - Aug 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.13
  • Arcadia Biosciences (RKDA) Announces First-Quarter 2021 Financial Results and Business Highlights
    PR Newswire

    Arcadia Biosciences (RKDA) Announces First-Quarter 2021 Financial Results and Business Highlights

    Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today released its financial and business results for the first quarter of 2021.

  • Arcadia Biosciences (RKDA) Acquires Lief Brands, a Portfolio of CBD and Wellness Brands
    PR Newswire

    Arcadia Biosciences (RKDA) Acquires Lief Brands, a Portfolio of CBD and Wellness Brands

    Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops and food ingredients, today announced it has acquired the assets of Lief Holdings, LLC and its portfolio of wellness products from The Parent Company, along with select assets of Live Zola, LLC. The acquisition includes leading consumer CBD brands like Soul SpringTM, the top selling CBD-infused botanical therapy brand in the natural category, as well as Saavy NaturalsTM, a leading line of all-natural body care products. The purchase price for these assets was $4.0 million in cash, plus 827,400 shares of Arcadia common stock.

  • ACCESSWIRE

    Arcadia Biosciences, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 17, 2021 / Arcadia Biosciences, Inc. (NASDAQ:RKDA) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 17, 2021 at 4:30 PM Eastern Time.